Parasitic worms and inflammatory diseases

Abstract

SUMMARY The debate on whether infection precipitates or prevents autoimmunity remains a contentious one. Recently the suggestion that some unknown microbe can be at the origin of some chronic inflammatory diseases has been countered by accumulating evidence that decreasing infection rates might have an important role to play in the rising prevalence of autoimmune disorders. The ‘Hygiene Hypothesis’ was initially postulated to explain the inverse correlation between the incidence of infections and the rise of allergic diseases, particularly in the developed world. Latterly, the Hygiene Hypothesis has been extended to also incorporate autoimmune diseases in general. Amongst the various infectious agents, a particular emphasis has been put on the interaction between parasitic worms and humans. Worm parasites have co‐evolved with the mammalian immune system for many millions of years and during this time, they have developed extremely effective strategies to modulate and evade host defences and so maintain their evolutionary fitness. It is therefore reasonable to conclude that the human immune system has been shaped by its relationship with parasitic worms and this may be a necessary requirement for maintaining our immunological health. Fully understanding this relationship may lead to novel and effective treatments for a host of deleterious inflammatory reactions.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 73

1. 1.

   Gale EA. The rise of childhood type 1 diabetes in the 20th century. Diabetes. 2002;51:3353-3361.

   Not in our library10.2337/diabetes.51.12.3353

2. 2.

   Pugliatti M, Sotgiu S, Rosati G. The worldwide prevalence of multiple sclerosis. Clin Neurol Neurosurg. 2002;104:182-191.

   Not in our library10.1016/s0303-8467(02)00036-7

3. 3.

   Kim MS, Polychronakos C. Immunogenetics of type 1 diabetes. Horm Res. 2005;64:180-188.

   Not in our library10.1159/000089190

4. 4.

   Kyvik KO, Green A, Beck-Nielsen H. Concordance rates of insulin dependent diabetes mellitus: a population based study of young Danish twins. Br Med J. 1995;311:913-917.

   Not in our library10.1136/bmj.311.7010.913

5. 5.

   Strachan DP. Hay fever, hygiene, and household size. Br Med J. 1989;299:1259-1260.

   Not in our library10.1136/bmj.299.6710.1259

6. 6.

   Chan-Yeung M, et al. The prevalence of asthma and asthma-like symptoms among adults in rural Beijing, China. Eur Respir J. 2002;19:853-858.

   Not in our library10.1183/09031936.02.00250602

7. 7.

   Perzanowski MS, et al. Atopy, asthma, and antibodies to Ascaris among rural and urban children in Kenya. J Pediatr. 2002;140:582-588.

   Not in our library10.1067/mpd.2002.122937

8. 8.

   Dunne DW, Cooke A. A worm's eye view of the immune system: consequences for evolution of human autoimmune disease. Nat Rev Immunol. 2005;5:420-426.

   Not in our library10.1038/nri1601

9. 9.

   Weinstock JV, et al. The possible link between de-worming and the emergence of immunological disease. J Lab Clin Med. 2002;139:334-338.

   Not in our library10.1067/mlc.2002.124343

10. 10.

    Kamradt T, Goggel R, Erb KJ. Induction, exacerbation and inhibition of allergic and autoimmune diseases by infection. Trends Immunol. 2005;26:260-267.

    Not in our library10.1016/j.it.2005.03.009

11. 11.

    Cooke A, et al. Infection and autoimmunity: are we winning the war, only to lose the peace? Trends Parasitol. 2004;20:316-321.

    Not in our library10.1016/j.pt.2004.04.010

12. 12.

    Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med. 2002;347:911-920.

    Not in our library10.1056/nejmra020100

13. 13.

    Wilfing A, et al. African–European differences in the capacity of T-cell cytokine production. Am J Trop Med Hyg. 2001;65:504-509.

    Not in our library10.4269/ajtmh.2001.65.504

14. 14.

    Banting FG, Best CH. Pancreatic extracts. 1922. J Lab Clin Med. 1990;115:254-272.

    Not in our library

15. 15.

    She JX. Susceptibility to type I diabetes: HLA-DQ DR revisited. Immunol Today. 1996;17:323-329.

    Not in our library10.1016/0167-5699(96)10014-1

16. 16.

    Todd JA. Genetic control of autoimmunity in type 1 diabetes. Immunol Today. 1990;11:122-129.

    Not in our library10.1016/0167-5699(90)90049-f

17. 17.

    Papadopoulos GK. Genetics of type I diabetes. Immunol Today. 1998;19:288-289.

    Not in our library10.1016/s0167-5699(98)01271-7

18. 18.

    Barker JM. Type 1 diabetes associated autoimmunity: natural history, genetic associations and screening. J Clin Endocrinol Metab. 2006.

    Not in our library10.1210/jc.2005-1679

19. 19.

    Variation and trends in incidence of childhood diabetes in Europe. Lancet. 2000;355:873-876.

    Not in our library

20. 20.

    Marrosu MG, et al. The co-inheritance of type 1 diabetes and multiple sclerosis in Sardinia cannot be explained by genotype variation in the HLA region alone. Hum Mol Genet. 2004;13:2919-2924.

    Not in our library10.1093/hmg/ddh319

21. 21.

    Joner G, Stene LC, Sovik O. Nationwide, prospective registration of type 1 diabetes in children aged < 15 years in Norway 1989–98: no increase but significant regional variation in incidence. Diabetes Care. 2004;27:1618-1622.

    Not in our library10.2337/diacare.27.7.1618

22. 22.

    Moussa MA, et al. Prevalence of type 1 diabetes among 6- to 18-year-old Kuwaiti children. Med Princ Pract. 2005;14:87-91.

    Not in our library10.1159/000083917

23. 23.

    Moussa MA, et al. Factors associated with type 1 diabetes in Kuwaiti children. Acta Diabetol. 2005;42:129-137.

    Not in our library10.1007/s00592-005-0192-0

24. 24.

    Ionescu-Tirgoviste C, et al. An increasing trend in the incidence of type 1 diabetes mellitus in children aged 0–14 years in Romania – ten years (1988–97) EURODIAB study experience. J Pediatr Endocrinol Metab. 2004;17:983-991.

    Not in our library10.1515/jpem.2004.17.7.983

25. 25.

    Makino S, et al. Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu. 1980;29:1-13.

    Not in our library10.1538/expanim1978.29.1_1

26. 26.

    Leiter EH, Serreze DV, Prochazka M. The genetics and epidemiology of diabetes in NOD mice. Immunol Today. 1990;11:147-149.

    Not in our library10.1016/0167-5699(90)90057-g

27. 27.

    Hutchings P, et al. Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages. Nature. 1990;348:639-642.

    Not in our library10.1038/348639a0

28. 28.

    Rosmalen JG, et al. Dendritic cells in the autoimmune insulitis in NOD mouse models of diabetes. Adv Exp Med Biol. 1997;417:291-294.

    Not in our library10.1007/978-1-4757-9966-8_47

29. 29.

    Kikutani H, Makino S. The murine autoimmune diabetes model: NOD and related strains. Adv Immunol. 1992;51:285-322.

    Not in our library10.1016/s0065-2776(08)60490-3

30. 30.

    Oldstone MB. Prevention of type I diabetes in nonobese diabetic mice by virus infection. Science. 1988;239:500-502.

    Not in our library10.1126/science.3277269

31. 31.

    Cooke A, et al. Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice. Parasite Immunol. 1999;21:169-176.

    Not in our library10.1046/j.1365-3024.1999.00213.x

32. 32.

    Zaccone P, et al. Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes. Eur J Immunol. 2003;33:1439-1449.

    Not in our library10.1002/eji.200323910

33. 33.

    Baxter AG, et al. Mycobacteria precipitate an SLE-like syndrome in diabetes-prone NOD mice. Immunology. 1994;83:227-231.

    Not in our library

34. 34.

    Bras A, Aguas AP. Diabetes-prone NOD mice are resistant to Mycobacterium avium and the infection prevents autoimmune disease. Immunology. 1996;89:20-25.

    Not in our library10.1046/j.1365-2567.1996.d01-717.x

35. 35.

    Zaccone P, et al. Salmonella typhimurium infection halts development of type 1 diabetes in NOD mice. Eur J Immunol. 2004;34:3246-3256.

    Not in our library10.1002/eji.200425285

36. 36.

    Wilberz S, et al. Persistent MHV (mouse hepatitis virus) infection reduces the incidence of diabetes mellitus in non-obese diabetic mice. Diabetologia. 1991;34:2-5.

    Not in our library10.1007/bf00404016

37. 37.

    Maizels RM, Yazdanbakhsh M. Immune regulation by helminth parasites: cellular and molecular mechanisms. Nat Rev Immunol. 2003;3:733-744.

    Not in our library10.1038/nri1183

38. 38.

    Maizels RM, et al. Helminth parasites – masters of regulation. Immunol Rev. 2004;201:89-116.

    Not in our library10.1111/j.0105-2896.2004.00191.x

39. 39.

    van Die I, et al. The dendritic cell-specific C-type lectin DC-SIGN is a receptor for Schistosoma mansoni egg antigens and recognizes the glycan antigen Lewis x. Glycobiology. 2003;13:471-478.

    Not in our library10.1093/glycob/cwg052

40. 40.

    van Kooyk Y, Geijtenbeek TB. DC-SIGN: escape mechanism for pathogens. Nat Rev Immunol. 2003;3:697-709.

    Not in our library10.1038/nri1182

41. 41.

    Hernandez HJ, Wang Y, Stadecker MJ. In infection with Schistosoma mansoni, B cells are required for T helper type 2 cell responses but not for granuloma formation. J Immunol. 1997;158:4832-4837.

    Not in our library

42. 42.

    Wilson MS, et al. Suppression of allergic airway inflammation by helminth-induced regulatory T cells. J Exp Med. 2005;202:1199-1212.

    Not in our library10.1084/jem.20042572

43. 43.

    Okano M, et al. Lacto-n-fucopentaose III found on Schistosoma mansoni egg antigens functions as adjuvant for proteins by inducing Th2-type response. J Immunol. 2001;167:442-450.

    Not in our library10.4049/jimmunol.167.1.442

44. 44.

    Hesse M, et al. The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells. J Immunol. 2004;172:3157-3166.

    Not in our library10.4049/jimmunol.172.5.3157

45. 45.

    McKee AS, Pearce EJ. CD25+CD4+ cells contribute to Th2 polarization during helminth infection by suppressing Th1 response development. J Immunol. 2004;173:1224-1231.

    Not in our library10.4049/jimmunol.173.2.1224

46. 46.

    Duez C, Gosset P, Tonnel AB. Dendritic cells and toll-like receptors in allergy and asthma. Eur J Dermatol. 2006;16:12-16.

    Not in our library

47. 47.

    Thomas PG, et al. A helminth glycan induces APC maturation via alternative NF-kappa B activation independent of I kappa B alpha degradation. J Immunol. 2005;175:2082-2090.

    Not in our library10.4049/jimmunol.175.4.2082

48. 48.

    Kane CM, et al. Helminth antigens modulate TLR-initiated dendritic cell activation. J Immunol. 2004;173:7454-7461.

    Not in our library10.4049/jimmunol.173.12.7454

49. 49.

    Herbert DR, et al. Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity. 2004;20:623-635.

    Not in our library10.1016/s1074-7613(04)00107-4

50. 50.

    Kronenberg M. Toward an understanding of NKT cell biology: progress and paradoxes. Annu Rev Immunol. 2005;23:877-900.

    Not in our library10.1146/annurev.immunol.23.021704.115742

51. 51.

    Faveeuw C, et al. Antigen presentation by CD1d contributes to the amplification of Th2 responses to Schistosoma mansoni glycoconjugates in mice. J Immunol. 2002;169:906-912.

    Not in our library10.4049/jimmunol.169.2.906

52. 52.

    Pearce EJ, et al. Th2 response polarization during infection with the helminth parasite Schistosoma mansoni. Immunol Rev. 2004;201:117-126.

    Not in our library10.1111/j.0105-2896.2004.00187.x

53. 53.

    Freeman CM, et al. CCR8 is expressed by antigen-elicited, IL-10-producing CD4+CD25+ T cells, which regulate Th2-mediated granuloma formation in mice. J Immunol. 2005;174:1962-1970.

    Not in our library10.4049/jimmunol.174.4.1962

54. 54.

    Jenkins SJ, Mountford AP. Dendritic cells activated with products released by schistosome larvae drive Th2-type immune responses, which can be inhibited by manipulation of CD40 costimulation. Infect Immun. 2005;73:395-402.

    Not in our library10.1128/iai.73.1.395-402.2005

55. 55.

    Taylor MD, et al. Removal of regulatory T cell activity reverses hyporesponsiveness and leads to filarial parasite clearance in vivo. J Immunol. 2005;174:4924-4933.

    Not in our library10.4049/jimmunol.174.8.4924

56. 56.

    Belkaid Y, et al. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature. 2002;420:502-507.

    Not in our library10.1038/nature01152

57. 57.

    La Flamme AC, Ruddenklau K, Backstrom BT. Schistosomiasis decreases central nervous system inflammation and alters the progression of experimental autoimmune encephalomyelitis. Infect Immun. 2003;71:4996-5004.

    Not in our library10.1128/iai.71.9.4996-5004.2003

58. 58.

    Nagayama Y, et al. Schistosoma mansoni and alpha-galactosylceramide: prophylactic effect of Th1 immune suppression in a mouse model of Graves’ hyperthyroidism. J Immunol. 2004;173:2167-2173.

    Not in our library10.4049/jimmunol.173.3.2167

59. 59.

    Sewell D, et al. Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization. Int Immunol. 2003;15:59-69.

    Not in our library10.1093/intimm/dxg012

60. 60.

    Elliott DE, et al. Exposure to schistosome eggs protects mice from TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol. 2003;284:G385-G391.

    Not in our library10.1152/ajpgi.00049.2002

61. 61.

    Khan WI, et al. Intestinal nematode infection ameliorates experimental colitis in mice. Infect Immun. 2002;70:5931-5937.

    Not in our library10.1128/iai.70.11.5931-5937.2002

62. 62.

    Summers RW, et al. Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease. Am J Gastroenterol. 2003;98:2034-2041.

    Not in our library10.1111/j.1572-0241.2003.07660.x

63. 63.

    Elliott DE, et al. Heligmosomoides polygyrus inhibits established colitis in IL-10-deficient mice. Eur J Immunol. 2004;34:2690-2698.

    Not in our library10.1002/eji.200324833

64. 64.

    McInnes IB, et al. A novel therapeutic approach targeting articular inflammation using the filarial nematode-derived phosphorylcholine-containing glycoprotein ES-62. J Immunol. 2003;171:2127-2133.

    Not in our library10.4049/jimmunol.171.4.2127

65. 65.

    Weinstock JV, Summers RW, Elliott DE. Role of helminths in regulating mucosal inflammation. Springer Semin Immunopathol. 2005;27:249-271.

    Not in our library10.1007/s00281-005-0209-3

66. 66.

    Summers RW, et al. Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology. 2005;128:825-832.

    Not in our library10.1053/j.gastro.2005.01.005

67. 67.

    Mayer L. A novel approach to the treatment of ulcerative colitis: is it kosher? Gastroenterology. 2005;128:1117-1119.

    Not in our library10.1053/j.gastro.2005.02.038

68. 68.

    Croese J, et al. A proof of concept study establishing Necator americanus in Crohn's patients and reservoir donors. Gut. 2006;55:136-137.

    Not in our library10.1136/gut.2005.079129

69. 69.

    Borkow G, Bentwich Z. Eradication of helminthic infections may be essential for successful vaccination against HIV and tuberculosis. Bull World Health Organ. 2000;78:1368-1369.

    Not in our library

70. 70.

    McElroy MD, et al. Coinfection with Schistosoma mansoni is associated with decreased HIV-specific cytolysis and increased IL-10 production. J Immunol. 2005;174:5119-5123.

    Not in our library10.4049/jimmunol.174.8.5119

71. 71.

    Bentwich Z. Concurrent infections that rise the HIV viral load. J HIV Ther. 2003;8:72-75.

    Not in our library

72. 72.

    Braschi S, et al. The tegument surface membranes of the human blood parasite Schistosoma mansoni: A proteomic analysis after differential extraction. Proteomics. 2006;6:1471-1482.

    Not in our library10.1002/pmic.200500368

73. 73.

    Wilson RA, et al. From genomes to vaccines via the proteome. Mem Inst Oswaldo Cruz. 2004;99(5 Suppl. 1):45-50.

    Not in our library10.1590/s0074-02762004000900008

Cited by papers we hold 2

• Training the Fetal Immune System Through Maternal Inflammation—A Layered Hygiene Hypothesis · 2020
  Not checked
• Helminth Immunomodulation in Autoimmune Disease · 2017
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.